AI Savvy CEO
    Greater Boston

    AI Consultant for Boston and Greater Boston Mid-Market CEOs

    AI Savvy provides strategic AI advisory to Boston and Greater Boston CEOs of $10M–$250M companies. Engagements include the AI Growth Audit, the 90-Day Execution Blueprint, and ongoing fractional Chief AI Officer support. Shawn Moore travels to Boston quarterly.

    Why Greater Boston mid-market is at an AI inflection point

    Boston is the global center of life sciences and one of the deepest AI research clusters in the US, and its mid-market is in the middle of an uneven AI inflection. RSM's 2025 Middle Market AI Survey found 91% of mid-market organizations across the US and Canada now use generative AI in operations, but the same survey flagged that governance maturity and internal expertise still lag adoption sharply across every US metro.

    Greater Boston runs on life sciences, higher education, financial services, and defense/robotics. MIT, Harvard, and the Broad Institute anchor the research bench; the operating question for mid-market CEOs here is discipline, not access.

    What we do for Boston companies

    Massachusetts-specific considerations

    Massachusetts data privacy law, FDA SaMD guidance (for health-adjacent AI), HIPAA, and the emerging Massachusetts AI Strategic Plan (2024–2025) all apply. Life sciences engagements additionally navigate 21 CFR Part 11 and applicable clinical-trial frameworks.

    Talent isn't scarce in Boston; disciplined executive prioritization is. Most engagements center on triaging a long list of promising pilots into a short list of production commitments.

    How we work with Boston clients

    Most Boston engagements run on a hybrid cadence: on-site working sessions when scope warrants, weekly video steering meetings, and async document review between sessions. Shawn Moore travels to Boston quarterly. Engagements are invoiced in USD; Canadian entities of US clients can be billed in CAD on request.

    Industries we focus on in Greater Boston

    Life sciences and pharma

    Biotech, diagnostics, and pharma applying AI to R&D, clinical operations, and regulatory reporting under FDA and HIPAA frameworks.

    Financial services and asset management

    Boston asset managers, wealth managers, and insurers navigating SEC oversight and NAIC AI Model Bulletin expectations.

    Robotics and defense

    Greater Boston robotics and defense-tech companies applying AI under ITAR/EAR and DoD procurement rules.

    Foundational reading before we talk

    Frequently asked questions

    Book a Boston strategy call

    Thirty minutes, no slides, no software pitch. Bring your AI portfolio, an active proposal, or a single decision on your desk. Leave with a written second opinion.

    Book a Strategic Call